Amyloid-beta and depression in healthy older adults: A systematic review

Objective: Depression has been shown to be a risk factor for Alzheimer's disease (AD), and in older adults may provide a marker for the beginning of the prodromal phase of AD. The purpose of this systematic review is to examine the relationship between amyloid- (A), a key biomarker of AD, and depression in older adults. Method: The literature search was limited to studies conducted from 2006 to 2014 that were published in English in peer-reviewed journals. Studies were selected if they included a group of older adults who either met established criteria for Major Depressive Disorder or Dysthymia; or were assessed for depressive symptoms on a standardised measure. Studies were also required to include an outcome variable that was a direct measure of A levels in either blood or cerebrospinal fluid (CSF) samples, or via neuroimaging techniques such as positron emission tomography (PET). Results: Nineteen studies were identified, 15 of which found significant differences in A levels between depressed and non-depressed older adults. However, studies were limited by their cross-sectional design, reliance on blood-based measures of A, and potential sample bias. Conclusions: Future investigations should consider prospective longitudinal design using neuroimaging and CSF measures of A.